Reuptake inhibitors tend to block releasers (that is, they don't cancel each other out but you'll get the side effects of both but only the catecholaminergic effects of the RI). Amp & methylphenidate are an example. Bupropion is a dirty one which influences some other systems like acetylcholine and glutamate and is only a very weak dopamine RI so it's a bad example.
Notice that pure reuptake inhibitors have few acute effects because the increase in transmitters hit their relative autoreceptors which makes the neurons to release less of them. That's why SSRIs take some days to weeks for them to become effective, before you only get some disequilibrium and with dopamine it's the same. Only thing which works are norepinephrine reuptake inhibitors but they have few benefits on their own (see reboxetine).
We have some 'reuptake inhibitors' like cocaine or methylphenidate which in reality are inverse agonists, so cause release by a different method than the releasers and still interfere with each other. But that's theory, I guess in lower doses you'll still get increased transmitter levels from adding e.g. methylphenidate to amphetamine.